158 related articles for article (PubMed ID: 12865588)
1. Miltefosine: great expectations against visceral leishmaniasis.
More B; Bhatt H; Kukreja V; Ainapure SS
J Postgrad Med; 2003; 49(1):101-3. PubMed ID: 12865588
[No Abstract] [Full Text] [Related]
2. Miltefosine: an oral drug for visceral leishmaniasis.
Prasad R; Kumar R; Jaiswal BP; Singh UK
Indian J Pediatr; 2004 Feb; 71(2):143-4. PubMed ID: 15053378
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].
Gangneux JP; Marty P
Sante; 2001; 11(4):257-8. PubMed ID: 11861203
[No Abstract] [Full Text] [Related]
4. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
Bhattacharya A; Ouellette M
EBioMedicine; 2018 Nov; 37():13-14. PubMed ID: 30314891
[No Abstract] [Full Text] [Related]
5. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
6. Miltefosine for visceral leishmaniasis.
Eibl H
N Engl J Med; 2000 Mar; 342(12):894-5. PubMed ID: 10733376
[No Abstract] [Full Text] [Related]
7. Miltefosine for Indian visceral leishmaniasis.
Roca B
N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12608397
[No Abstract] [Full Text] [Related]
8. Miltefosine for visceral leishmaniasis.
Sherwood JA
N Engl J Med; 2000 Mar; 342(12):895. PubMed ID: 10733377
[No Abstract] [Full Text] [Related]
9. Miltefosine for Indian visceral leishmaniasis.
Agarwal PK
N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12606744
[No Abstract] [Full Text] [Related]
10. Miltefosine presents new hope for leishmaniasis patients.
Paterson R
Lancet Infect Dis; 2002 Aug; 2(8):452. PubMed ID: 12150830
[No Abstract] [Full Text] [Related]
11. Miltefosine--the long-awaited therapy for visceral leishmaniasis?
Herwaldt BL
N Engl J Med; 1999 Dec; 341(24):1840-2. PubMed ID: 10588972
[No Abstract] [Full Text] [Related]
12. Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction.
Kumar N; Pandey K; Das VN; Sinha PK; Topno RK; Verma N; Lal CS; Das P; Bhattacharya SK
Ann Trop Med Parasitol; 2007 Oct; 101(7):649-51. PubMed ID: 17877883
[No Abstract] [Full Text] [Related]
13. Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine.
Avasthi R; Chaudhary SC; Khanna S
Indian J Med Microbiol; 2009; 27(1):85-6. PubMed ID: 19172077
[No Abstract] [Full Text] [Related]
14. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India.
Thakur CP; Sinha PK; Singh RK; Hassan SM; Narain S
Trans R Soc Trop Med Hyg; 2000; 94(6):696-7. PubMed ID: 11198660
[No Abstract] [Full Text] [Related]
15. What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?
Sundar S; Singh A
Expert Rev Anti Infect Ther; 2013 Feb; 11(2):117-9. PubMed ID: 23409817
[No Abstract] [Full Text] [Related]
16. Treatment of leishmaniasis with miltefosine: 2008 status.
Berman JJ
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
[TBL] [Abstract][Full Text] [Related]
17. [Miltefosine: a new remedy for leishmaniasis].
Dorlo TP; Eggelte TA; Beijnen JH; de Vries PJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2697-701. PubMed ID: 17194005
[TBL] [Abstract][Full Text] [Related]
18. Miltefosine to treat leishmaniasis.
Berman J
Expert Opin Pharmacother; 2005 Jul; 6(8):1381-8. PubMed ID: 16013987
[TBL] [Abstract][Full Text] [Related]
19. Oral miltefosine in the treatment of kala-azar.
Mohan A; Seth S
Natl Med J India; 2000; 13(4):202-3. PubMed ID: 11002688
[No Abstract] [Full Text] [Related]
20. Leishmania resistance to miltefosine associated with genetic marker.
Cojean S; Houzé S; Haouchine D; Huteau F; Lariven S; Hubert V; Michard F; Bories C; Pratlong F; Le Bras J; Loiseau PM; Matheron S
Emerg Infect Dis; 2012 Apr; 18(4):704-6. PubMed ID: 22469394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
